Both in Pharmaceuticals
InMed Pharmaceuticals vs Pliant Therapeutics
Over the past year INM returned +405.8% and PLRX returned −47.1%; their daily moves had a correlation of -0.01.
INM +405.8% PLRX −47.1%Growth of $1, one year, split-adjusted
| Metric | INM | PLRX |
|---|---|---|
| Price | $8.75 | $0.8518 |
| Market cap | $48.1M | $52.7M |
| Today | +420.83% | −1.03% |
| 1 month | +557.9% | −17.3% |
| 6 months | +1104.6% | −30.7% |
| Year to date | +725.5% | −30.2% |
| 1 year | +373.0% | −49.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | 24.8× | — |
| Net cash | $2.2M | $158.1M |
| Dividend yield | — | — |
| Volatility (60d) | 338.3% | 50.5% |
| Short % of float | 0.1% | 9.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).